# Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

> **NCT00334048** · PHASE4 · COMPLETED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 9 (actual)

## Conditions studied

- Sexual Dysfunction

## Interventions

- **DRUG:** Ropinirole (Requip)

## Key facts

- **NCT ID:** NCT00334048
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2015-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00334048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00334048, "Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00334048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*